The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 20, 2017

Filed:

Aug. 01, 2012
Applicants:

Toshiya Kanaji, Osaka, JP;

Kazuhiro Fuchibe, Osaka, JP;

Masaya Takahashi, Osaka, JP;

Inventors:

Toshiya Kanaji, Osaka, JP;

Kazuhiro Fuchibe, Osaka, JP;

Masaya Takahashi, Osaka, JP;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/4015 (2006.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01); C07D 207/26 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4015 (2013.01); A61K 9/0019 (2013.01); A61K 9/2054 (2013.01); A61K 45/06 (2013.01); C07D 207/26 (2013.01);
Abstract

An agent for treating heart failure, which improves left ventricular diastolic function itself without depending on the diuretic effect or vasodilation effect; controls the pathological condition of diastolic functional failure; and prevents the recurrence, and can prevent dyspnea and death from the pathological condition, is provided. By directly acting on a heart, 4-[(2-{(2R)-2-[(1E,3S)-4-(4-fluorophenyl)-3-hydroxy-1-buten-1-yl]-5-oxo-1-pyrrolidinyl}ethyl)thio]butanoic acid improves left ventricular diastolic function, and can effectively treat diastolic functional failure among heart failure types. Accordingly, by present invention, a new agent for treating heart failure that can relieve diastolic functional failure, for which no effective therapeutic method has been established, can be provided.


Find Patent Forward Citations

Loading…